Tracked shipping to New Zealand with premium packaging for just NZ$15 

Ship to
New Zealand
0

My Account

  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

menu

Select your country

Americas

Europe

Rest of the world

portada Personalized Pathway-Activated Systems Imaging in Oncology: Principal and Instrumentation
Type
Physical Book
Publisher
Author
Language
English
Pages
243
Format
Hardcover
Dimensions
24.3x16.4x2 cm
Weight
0.83 kg.
ISBN13
9789811033483
Edition No.
1
Categories

Personalized Pathway-Activated Systems Imaging in Oncology: Principal and Instrumentation

Inoue, Tomio ; Yang, David ; Huang, Gang (Author) · Springer · Hardcover

Personalized Pathway-Activated Systems Imaging in Oncology: Principal and Instrumentation - Inoue, Tomio ; Yang, David ; Huang, Gang

Cheaper New Book Imported to New Zealand
Delivery: 15 Oct - 22 Oct Shipping: 15 to 16 business days.
NZ$ 357.01
Faster New Book Imported to New Zealand
Delivery: 13 Oct - 20 Oct Shipping: 13 to 14 business days.
NZ$ 406.55
Import costs and 15% GST included in the price ✅
NZ$ 357.01

Choose the list to add your product or create one New List

Go to My Wishlists
Calculate shipping cost

Synopsis "Personalized Pathway-Activated Systems Imaging in Oncology: Principal and Instrumentation"

This comprehensive volume covers radiopharmaceuticals developed for pathway-directed systems in imaging and theranostic applications. We now are at the cutting edge of providing personalized treatment with increased use in oncology of these new radiopharmaceuticals. Trends in high-resolution instrumentation development, quality assurance systems and regulatory compliance for radiopharmaceuticals, clinical evaluation of radiopharmaceuticals, and benefits and pitfalls of the current clinical FDG PET are discussed.Radiopharmaceuticals are used for diagnosis of diseases of the central nervous and cardiovascular systems and for staging, restaging, and treatment planning for cancers. Nuclear biomarkers allow precise measurement of molecular pathways on a whole-body image upon administration of functional radiolabeled agents, and nuclear imaging agentshave potential use in patient selection, pharmacokinetic, dosage-finding, and proof-of-concept studies. Nuclear imaging agents and hybrid instrumentation also provide sensitive and specific answers for differential responsiveness in therapeutic outcome.This book serves as a reference for moving the discovery and development of radiopharmaceuticals from the workbench to clinical applications. It thus benefits not only clinicians but also translational research scientists--molecular biologists, chemists, imaging scientists, pharmaceutical developers, physicists, and support staff.

Customers reviews

More customer reviews
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)
  • 0% (0)

Frequently Asked Questions about the Book

Is the book original?

All books in our catalog are Original.

In what language is the book written?

The book is written in English.

What is the format of this book?

The binding of this edition is Hardcover.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews